1. Home
  2. CUE vs FSHP Comparison

CUE vs FSHP Comparison

Compare CUE & FSHP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CUE
  • FSHP
  • Stock Information
  • Founded
  • CUE 2014
  • FSHP 2018
  • Country
  • CUE United States
  • FSHP United States
  • Employees
  • CUE N/A
  • FSHP N/A
  • Industry
  • CUE Biotechnology: Pharmaceutical Preparations
  • FSHP
  • Sector
  • CUE Health Care
  • FSHP
  • Exchange
  • CUE Nasdaq
  • FSHP NYSE
  • Market Cap
  • CUE 94.4M
  • FSHP 90.7M
  • IPO Year
  • CUE 2018
  • FSHP 2024
  • Fundamental
  • Price
  • CUE $1.43
  • FSHP $10.23
  • Analyst Decision
  • CUE Strong Buy
  • FSHP
  • Analyst Count
  • CUE 5
  • FSHP 0
  • Target Price
  • CUE $5.00
  • FSHP N/A
  • AVG Volume (30 Days)
  • CUE 234.5K
  • FSHP 7.0K
  • Earning Date
  • CUE 03-10-2025
  • FSHP 01-01-0001
  • Dividend Yield
  • CUE N/A
  • FSHP N/A
  • EPS Growth
  • CUE N/A
  • FSHP N/A
  • EPS
  • CUE N/A
  • FSHP 0.11
  • Revenue
  • CUE $9,532,000.00
  • FSHP N/A
  • Revenue This Year
  • CUE $73.11
  • FSHP N/A
  • Revenue Next Year
  • CUE $11.02
  • FSHP N/A
  • P/E Ratio
  • CUE N/A
  • FSHP $90.07
  • Revenue Growth
  • CUE 149.53
  • FSHP N/A
  • 52 Week Low
  • CUE $0.45
  • FSHP $9.99
  • 52 Week High
  • CUE $2.37
  • FSHP $10.25
  • Technical
  • Relative Strength Index (RSI)
  • CUE 54.52
  • FSHP N/A
  • Support Level
  • CUE $1.22
  • FSHP N/A
  • Resistance Level
  • CUE $1.54
  • FSHP N/A
  • Average True Range (ATR)
  • CUE 0.12
  • FSHP 0.00
  • MACD
  • CUE 0.00
  • FSHP 0.00
  • Stochastic Oscillator
  • CUE 67.65
  • FSHP 0.00

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune disease with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103 and others.

About FSHP FLAG SHIP ACQUISITION CORPORATION

Flag Ship Acquisition Corp is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

Share on Social Networks: